Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.22% is 35% above its 5-year average of -62.11%, near the high end of its 5-year range (-115.71%–-21.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.07% above its 12-month average of -49.70%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -40.22%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-49.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-69.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-62.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-42.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-57.83%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.07%
CURRENT VS 3Y AVG
+41.76%
CURRENT VS 5Y AVG
+35.24%
CURRENT VS 10Y AVG
+5.85%
CURRENT VS 15Y AVG
+30.45%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.07%
median of 785 covered companies
CURRENT VS SECTOR MEDIAN
-14.69%
vs the sector median at left
iBio, Inc.
Market Cap
$67.52M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-49.70%
3Y Avg
-69.07%
5Y Avg
-62.11%
Market Cap
$67.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-401.98%
3Y Avg
-245.26%
5Y Avg
-207.94%
Market Cap
$67.93M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$66.07M
Return on Invested Capital (ROIC)
-37.01%
TTM Avg
-30.52%
3Y Avg
-23.08%
5Y Avg
-17.79%
Market Cap
$69.19M
Return on Invested Capital (ROIC)
13.12%
TTM Avg
-58.05%
3Y Avg
-35.80%
5Y Avg
-42.97%
Market Cap
$64.92M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
Market Cap
$69.78M
Return on Invested Capital (ROIC)
-153.46%
TTM Avg
-63.13%
3Y Avg
-47.00%
5Y Avg
-35.71%
Market Cap
$70.16M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
20.47%
3Y Avg
-36.30%
5Y Avg
-23.36%
Market Cap
$64.20M
Return on Invested Capital (ROIC)
-139.74%
TTM Avg
-190.33%
3Y Avg
-1114.56%
5Y Avg
-840.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iBio, Inc. (IBIO) | $67.52M | -40.22% | -49.70% | -69.07% | -62.11% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $67.77M | N/A | -401.98% | -245.26% | -207.94% |
| Fortress Biotech, Inc. (FBIO)vs › | $67.93M | -10.85% | -101.00% | -120.85% | -96.47% |
| XBiotech Inc. (XBIT)vs › | $66.07M | -37.01% | -30.52% | -23.08% | -17.79% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.19M | 13.12% | -58.05% | -35.80% | -42.97% |
| Cingulate Inc. (CING)vs › | $64.92M | -83.74% | -153.15% | -164.21% | -165.99% |
| MindWalk Holdings Corp. (HYFT)vs › | $69.78M | -153.46% | -63.13% | -47.00% | -35.71% |
| Champions Oncology, Inc. (CSBR)vs › | $70.16M | -6.75% | 20.47% | -36.30% | -23.36% |
| RenovoRx, Inc. (RNXT)vs › | $64.20M | -139.74% | -190.33% | -1114.56% | -840.48% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.35M | -6.79% | -4.87% | -47.70% | -62.00% |
ROIC
-40.2%
ROE
-38.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.22% |
| 2026-03-31 | -30.00% |
| 2025-12-31 | -39.28% |
| 2025-09-30 | -34.77% |
| 2025-06-30 | -104.24% |
| 2025-03-31 | -115.71% |
| 2024-12-31 | -90.33% |
| 2024-09-30 | -73.50% |
| 2024-06-30 | -66.24% |
| 2024-03-31 | -43.74% |
| 2023-12-31 | -80.97% |
| 2023-09-30 | -90.59% |
| 2023-06-30 | -88.32% |
| 2023-03-31 | -115.26% |
| 2022-12-31 | -104.64% |
| 2022-09-30 | -51.70% |
| 2022-06-30 | -39.66% |
| 2022-03-31 | -26.78% |
| 2021-12-31 | -24.64% |
| 2021-09-30 | -21.68% |
| 2021-06-30 | -22.08% |
| 2021-03-31 | -17.93% |
| 2020-12-31 | -15.36% |
| 2020-09-30 | -15.17% |
| 2020-06-30 | -15.70% |
| 2020-03-31 | -40.62% |
| 2019-12-31 | -46.88% |
| 2019-09-30 | -51.80% |
| 2019-06-30 | -58.20% |
| 2019-03-31 | -49.58% |
| 2018-12-31 | -42.96% |
| 2018-09-30 | -39.13% |
| 2018-06-30 | -34.66% |
| 2018-03-31 | -48.61% |
| 2017-12-31 | -44.21% |
| 2017-09-30 | -45.95% |
| 2017-06-30 | -41.76% |
| 2017-03-31 | -34.42% |
| 2016-12-31 | -28.95% |
| 2016-09-30 | -24.37% |
| 2016-06-30 | -19.99% |
| 2016-03-31 | -18.74% |
| 2015-12-31 | -97.12% |
| 2015-09-30 | -72.01% |
| 2015-06-30 | -59.35% |
| 2015-03-31 | -58.09% |
| 2014-12-31 | -57.77% |
| 2014-09-30 | -101.07% |
| 2014-06-30 | -62.98% |
| 2014-03-31 | -57.02% |
| 2013-12-31 | -57.30% |
| 2013-09-30 | -79.85% |
| 2013-06-30 | -131.55% |
| 2013-03-31 | -326.94% |
| 2012-12-31 | -210.77% |
| 2012-09-30 | -192.79% |
| 2012-06-30 | -151.21% |
| 2012-03-31 | -156.25% |
| 2011-12-31 | -3737.08% |
| 2011-09-30 | -1197.04% |
| 2011-03-31 | -115.10% |
| 2010-12-31 | -298.53% |
| 2010-06-30 | -426.25% |
| 2010-03-31 | -94.47% |
| 2009-12-31 | -40.99% |
| 2009-09-30 | -29.21% |
| 2009-06-30 | -43.91% |
| 2009-03-31 | -42.81% |
| 2008-12-31 | -43.59% |
| 2008-09-30 | -35.52% |
| 2008-06-30 | -115.18% |
